Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab

Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab

Vernal keratoconjunctivitis (VKC) is a severe ocular allergic disease characterized by chronic inflammation of the cornea and conjunctiva that may lead to loss of visual acuity and blindness. The disease occurs primarily in children and is more common in geographical regions characterized by warm te...

Full description

Bibliographic Details
Main Authors: Serge Doan, MD, Nikolaos G. Papadopoulos, MD, Jason K. Lee, MD, Salvatore Leonardi, MD, Sara Manti, MD, Susanne Lau, Carmen Rondon, Vibha Sharma, MD, Uwe Pleyer, MD, Xavier Jaumont, MD, Slawomir B. Lazarewicz, MD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:World Allergy Organization Journal
Subjects:
Vernal keratoconjunctivitis
Allergy
IgE
Biologics
Omalizumab
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000480

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000480

Similar Items